ID

31495

Descripción

Study ID: 104574 Clinical Study ID: AR1104574 Study Title: A randomized blinded pilot trial of fondaparinux sodium (Arixtra®) versus unfractionated heparin in addition to standard therapy in a broad range of patients undergoing percutaneous coronary intervention (ASPIRE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: fondaparinux sodium Trade Name: Arixtra Study Indication: Thromboembolism

Palabras clave

Versiones (2)
  1. 28/8/18 28/8/18 -
  2. 28/8/18 28/8/18 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

28 de agosto de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Fondaparinux sodium (Arixtra) versus unfractionated heparin with patients undergoing PCI; Study ID: 104574

Inglés

Blinded Anticoagulation Form

1 formularios  
Administrative Data
Descripción

Administrative Data

Alias
UMLS CUI-1
C1320722
Patient ID, Centre No.
Descripción

Patient ID; Centre Number

Tipo de datos

text

Alias
UMLS CUI [1,1]
C1269815
UMLS CUI [1,2]
C2825181
UMLS CUI [1,3]
C1300638
Patient ID, Envelope No.
Descripción

Patient ID; Envelope Number

Tipo de datos

text

Alias
UMLS CUI [1,1]
C1269815
UMLS CUI [1,2]
C2348585
Patient Initials
Descripción

Patient Initials

Tipo de datos

text

Alias
UMLS CUI [1]
C2986440
Study Drug Accountability
Descripción

Study Drug Accountability

Alias
UMLS CUI-1
C0013175
UMLS CUI-2
C0078889
The treatment allocation for this patient was
Descripción

treatment allocation

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C1706778
Was the patient given the treatment allocated?
Descripción

allocated treatment given

Tipo de datos

text

Alias
UMLS CUI [1,1]
C1706778
UMLS CUI [1,2]
C0580351
The actual treatment given to this patient was
Descripción

actual treatment

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0237400
ACT Measurement
Descripción

ACT Measurement

Alias
UMLS CUI-1
C0427611
Was an ACT measured during PCI procedure?
Descripción

ACT measurement during PCI

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0427611
UMLS CUI [1,2]
C0347984
UMLS CUI [1,3]
C1532338
Was the ACT revealed to the investigator or interventional cardiologist during PCI?
Descripción

ACT measurement; research personnel informed

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0427611
UMLS CUI [1,2]
C0035173
UMLS CUI [1,3]
C1522154
Was additional anticoagulant requested by the investigator during the PCI procedure?
Descripción

additional anticoagulant therapy during PCI

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0150457
UMLS CUI [1,2]
C1524062
UMLS CUI [1,3]
C0347984
UMLS CUI [1,4]
C1532338
Volver a la parte superior de la página

Similar models

Blinded Anticoagulation Form

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
Patient ID; Centre Number
Item
Patient ID, Centre No.
text
C1269815 (UMLS CUI [1,1])
C2825181 (UMLS CUI [1,2])
C1300638 (UMLS CUI [1,3])
Patient ID; Envelope Number
Item
Patient ID, Envelope No.
text
C1269815 (UMLS CUI [1,1])
C2348585 (UMLS CUI [1,2])
Patient Initials
Item
Patient Initials
text
C2986440 (UMLS CUI [1])
Item Group
Study Drug Accountability
C0013175 (UMLS CUI-1)
C0078889 (UMLS CUI-2)
Item
The treatment allocation for this patient was
text
C0087111 (UMLS CUI [1,1])
C1706778 (UMLS CUI [1,2])
treatment allocation
Code List
The treatment allocation for this patient was
CL Item
unfractionated heparin (unfractionated heparin)
CL Item
fondaparinux 2.5 mg (fondaparinux 2.5 mg)
CL Item
fondaparinux 5.0 mg (fondaparinux 5.0 mg)
Item
Was the patient given the treatment allocated?
text
C1706778 (UMLS CUI [1,1])
C0580351 (UMLS CUI [1,2])
allocated treatment given
Code List
Was the patient given the treatment allocated?
CL Item
Yes (Yes)
CL Item
No (give reason) (No (give reason))
Item
The actual treatment given to this patient was
text
C0087111 (UMLS CUI [1,1])
C0237400 (UMLS CUI [1,2])
actual treatment
Code List
The actual treatment given to this patient was
CL Item
unfractionated heparin (specify amount, brand name and lot number) (unfractionated heparin (specify amount, brand name and lot number))
CL Item
fondaparinux 2.5 mg (specify batch number) (fondaparinux 2.5 mg (specify batch number))
CL Item
fondaparinux 5.0 mg (specify batch number) (fondaparinux 5.0 mg (specify batch number))
Item Group
ACT Measurement
C0427611 (UMLS CUI-1)
Item
Was an ACT measured during PCI procedure?
text
C0427611 (UMLS CUI [1,1])
C0347984 (UMLS CUI [1,2])
C1532338 (UMLS CUI [1,3])
ACT measurement during PCI
Code List
Was an ACT measured during PCI procedure?
CL Item
No (No)
CL Item
Yes (give seconds, date and time) (Yes (give seconds, date and time))
Item
Was the ACT revealed to the investigator or interventional cardiologist during PCI?
text
C0427611 (UMLS CUI [1,1])
C0035173 (UMLS CUI [1,2])
C1522154 (UMLS CUI [1,3])
ACT measurement; revelation investigator
Code List
Was the ACT revealed to the investigator or interventional cardiologist during PCI?
CL Item
No (No)
CL Item
Yes (give reason) (Yes (give reason))
Item
Was additional anticoagulant requested by the investigator during the PCI procedure?
text
C0150457 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])
C0347984 (UMLS CUI [1,3])
C1532338 (UMLS CUI [1,4])
undefined item
Code List
Was additional anticoagulant requested by the investigator during the PCI procedure?
CL Item
No (No)
CL Item
Yes - 2000 IU unfractioned heparin (give Brand name, Lot number, Date and time of injection) (Yes - 2000 IU unfractioned heparin (give Brand name, Lot number, Date and time of injection))
CL Item
Yes - fondaparinux 2.5mg (give Batch number, Date and time of injection) (Yes - fondaparinux 2.5mg (give Batch number, Date and time of injection))
CL Item
Yes - saline (give Date and time of injection) (Yes - saline (give Date and time of injection))
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial